BOSTON--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO) today provided an update on integration activities that further enhance its full-service clinical research offerings and align its regulatory and validation consulting to improve its competitive position. Clinical staffing services will continue to be offered.
